Aminoglycoside nephrotoxicity in obstructive jaundice

doi:10.1016/0002-9343(88)90501-3

The American Journal of Medicine

Volume 85, Issue 1, July 1988, Pages 47-50

https://doi.org/10.1016/0002-9343(88)90501-3 Get rights and content

Abstract

Purpose: Although it is known that liver disease predisposes to aminoglycoside nephrotoxicity, specific features of such disease that may predispose to aminoglycoside-induced renal injury have not been identified. We sought to identify such features.

Patients and methods: We undertook a retrospective review of the charts of 42 consecutive patients with biliary obstruction and/or cholangitis who had received more than three doses of an aminoglycoside.

Results: Comparison of patients in whom aminoglycoside nephrotoxicity did and did not develop revealed no differences in age, race, sex, dose, and duration of aminoglycoside therapy; mean peak and trough aminoglycoside levels; initial pre-treatment levels of serum creatinine, aspartate transaminase, alkaline phosphatase, or albumin; or prothrombin time. The initial pre-treatment serum bilirubin level was higher in the patients in whom aminoglycoside nephrotoxicity developed (12.2 ± 8.8 mg/dl versus 3.4 ± 3.2 mg/dl, p <0.01). Aminoglycoside nephrotoxicity occurred in eight patients (19 percent): in seven of 15 patients (47 percent) with an initial bilirubin value greater than 5.0 mg/dl, but in only one of 27 patients (4 percent) with an initial bilirubin value below 5.0 mg/dl (p <0.01). The pre-treatment bilirubin level correlated with the change in creatinine during aminoglycoside therapy (n = 42, r = 0.66, p <0.01).

Conclusion: Aminoglycosides should probably be avoided in patients with biliary obstruction and a high serum bilirubin level.

References (16)

RD Moore et al.
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides
Am J Med
(1986)
JC Wade et al.
Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside
Lancet
(1978)
J Cabrera et al.
Aminoglycoside nephrotoxicity in cirrhosis
Gastroenterology
(1982)
CR Smith et al.
Double-blind clinical trials of aminoglycoside-induced nephrotoxicity
RD Moore et al.
Risk factors for nephrotoxicity in patients treated with aminoglycosides
Ann Intern Med
(1984)
RA Zager et al.
Gentamicin and gram-negative bacteremia
J Clin Invest
(1986)
IC Bygbjerg et al.
Gentamicin-induced nephropathy
Scand J Infect Dis
(1976)
CL Bendush et al.
Tobramycin sulfate: a summary of worldwide experience from clinical trials
J Infect Dis
(1976)

There are more references available in the full text version of this article.

Cited by (42)

Infections of the Biliary Tract
2013, Gastrointestinal Endoscopy Clinics of North America
Citation Excerpt :
The traditional antibiotic regimen for cholangitis comprised a combination of an aminoglycoside and ampicillin. However, because of high rates of drug toxicity and emerging drug resistance,63,64 these have largely been replaced by more efficacious regimens such as broad-spectrum penicillins, cephalosporins, and fluoroquinolones. Extended-spectrum penicillins, such as piperacillin, are effective against the common organisms causing cholangitis, including aerobic and anaerobic gram-negative bacilli, and Enterococcus species.
Acute cholangitis
2010, Enfermedades Infecciosas y Microbiologia Clinica
La colangitis aguda es una infección potencialmente grave de las vías biliares, que se produce como consecuencia de una obstrucción a dicho nivel. La litiasis coledocal es la causa más frecuente de la colangitis. La obstrucción de la vía biliar y la colonización bacteriana subsiguiente condicionan la aparición de la infección. Los microorganismos de la flora entérica, aerobios y, en menor grado, anaerobios, son los agentes causales en la mayoría de casos. La denominada tríada de Charcot constituye la sintomatología clínica más frecuente. El diagnóstico se confirma mediante técnicas radiológicas abdominales, entre las que se incluyen la ecografía, la tomografía computarizada y la colangiorresonancia magnética, en las que se detectan signos de obstrucción de la vía biliar y, en muchas ocasiones, la causa subyacente de ésta. El tratamiento antimicrobiano apropiado precoz y el drenaje biliar, generalmente efectuado mediante técnicas endoscópicas, son la terapia de elección en la mayoría de pacientes.
Acute cholangitis is a potentially severe infection of the biliary tract, resulting from a biliary obstruction. The most frequent cause of cholangitis is common duct stones. Biliary tract obstruction and secondary bacterial colonization lead to infection. In most cases, the causative agents are intestinal microflora, mostly aerobic microorganisms (and, to a lesser extent, anaerobic bacteria). The Charcot triad constitutes the most frequent symptomatology. Diagnosis is confirmed by means of radiological techniques, such as ultrasonography, computed tomography scan, or magnetic resonance imaging of the liver, in which signs of obstruction of the biliary tract can be detected and its etiology can often be determined. In most patients the treatment of choice is early appropriate antimicrobial therapy and biliary drainage, generally using endoscopic techniques.
Predictors of acute kidney injury associated with intravenous colistin treatment
2010, International Journal of Antimicrobial Agents
Colistimethate sodium (CMS) was recently re-introduced into clinical practice as a last resort for the treatment of nosocomial infections caused by multiresistant bacteria. This retrospective cohort study was designed to identify predictors of acute kidney injury (AKI) associated with intravenous (i.v.) CMS treatment. From March 2007 to July 2008, 71 adult patients receiving CMS for ≥72 h were enrolled. AKI was defined using Risk, Injury, Failure, Loss and End-stage kidney disease (RIFLE) criteria according to serum creatinine. The median total dose of CMS was 54.3 mg/kg (range 27.5–94.5 mg/kg). AKI developed in 38 patients (53.5%). Cox regression analysis based of cumulative CMS dose (mg/kg) identified four independent predictors of AKI: male sex [hazard ratio (HR) = 3.55, 95% confidence interval (CI), 1.47–8.55]; concomitant use of a calcineurin inhibitor (HR = 6.74, 95% CI 2.49–18.24); hypoalbuminaemia (serum albumin level <2.0 g/dL) (HR = 6.29, 95% CI 2.04–19.39); and hyperbilirubinaemia (total bilirubin level >5 mg/dL) (HR = 3.53, 95% CI 1.17–10.71). In conclusion, AKI was a common complication of i.v. CMS treatment. Male sex, concomitant use of calcineurin inhibitors, hypoalbuminaemia and hyperbilirubinaemia were independent predictors of AKI. The effect of AKI on patient outcomes was not determined.
Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation
2007, American Journal of Transplantation
Acute renal failure (ARF) can complicate up to 60% of orthotopic liver transplants (OLT). The RIFLE criteria were developed to provide a consensus definition for acute renal disease in critically ill patients. Using the RIFLE criteria, we aimed to determine the incidence and risk factors for ARF and acute renal injury (ARI), and to evaluate the link with the outcomes, patient survival and length of hospital stay. Three hundred patients, who received 359 OLTs, were retrospectively analyzed. ARI and ARF occurred post 11.1 and 25.7% of OLTs, respectively. By multivariate analysis, ARI was associated with pre-OLT hypertension and alcoholic liver disease and ARF with higher pre-OLT creatinine, inotrope and aminoglycoside use. ARF, but not ARI, had an impact on 30-day and 1-year patient survival and longer length of hospital stay. ARI and ARF, as defined by the RIFLE criteria, are common complications of OLT, with distinct risk factors and ARF has serious clinical consequences. The development of a consensus definition is a welcome advance, however these criteria do need to be validated in large studies in a wide variety of patient populations.
Approach to the Patient Who Has Suspected Acute Bacterial Cholangitis
2006, Gastroenterology Clinics of North America
Citation Excerpt :
Antibiotics do not reach the biliary system until about 24 hours after drainage has been accomplished. Broad-spectrum coverage is preferred and although the combination of ampicillin and gentamicin is popular, there are disadvantages: limited anaerobic coverage, frequent microbial resistance, and nephrotoxicity [50]. In extremely ill or elderly patients, anaerobic coverage is added because a mixed infection is likely.
Diagnosis and management of cholecystitis and cholangitis
2003, Gastroenterology Clinics of North America

View all citing articles on Scopus

View full text

Original articleAminoglycoside nephrotoxicity in obstructive jaundice

Abstract

Am J Med

Lancet

Gastroenterology

Double-blind clinical trials of aminoglycoside-induced nephrotoxicity

Risk factors for nephrotoxicity in patients treated with aminoglycosides

Ann Intern Med

Gentamicin and gram-negative bacteremia

J Clin Invest

Gentamicin-induced nephropathy

Scand J Infect Dis

Tobramycin sulfate: a summary of worldwide experience from clinical trials

J Infect Dis

Original article
Aminoglycoside nephrotoxicity in obstructive jaundice